Neko Health raised €250M in a Series B round in Jan 2025. The company is based in Stockholm, Sweden. Investors in the round: Lightspeed Venture Partners. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
